Cargando…
Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
PURPOSE: Strategies for neuroprotection are the main targets of glaucoma research. The neuroprotective properties of SRT2104 administration have been proven in central nervous system degeneration diseases through the activation of nicotinamide adenine dinucleotide-dependent deacetylase-silence infor...
Autores principales: | Bai, Xue, Ye, Dan, Shi, Yuxun, Fan, Matthew, Lu, Peng, Feng, Yanlin, Hu, Chenyang, Liao, Jing, Cui, Kaixuan, Tang, Xiaoyu, Wu, Peiqi, Xu, Fan, Xu, Yue, Huang, Jingjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148658/ https://www.ncbi.nlm.nih.gov/pubmed/37099021 http://dx.doi.org/10.1167/iovs.64.4.31 |
Ejemplares similares
-
Cardiovascular Effects of a Novel SIRT1 Activator, SRT2104, in Otherwise Healthy Cigarette Smokers
por: Venkatasubramanian, Sowmya, et al.
Publicado: (2013) -
Cardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitus
por: Noh, Radzi M, et al.
Publicado: (2017) -
Sirtuin 1 activator SRT2104 protects Huntington's disease mice
por: Jiang, Mali, et al.
Publicado: (2014) -
Occurrence of Oxidative Stress and Premature Senescence in the Anterior Segment of Acute Primary Angle-Closure Eyes
por: Ye, Dan, et al.
Publicado: (2022) -
A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis
por: Krueger, James G., et al.
Publicado: (2015)